Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07137312 · ClinicalTrials.gov registry record
Ex Vivo Expansion (ACT-X)
A clinical trial of Healthy and Solid Tumor, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 24
- Enrollment target
- 1
- Study location
NCT07137312 is a study of Healthy and Solid Tumor that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 24 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07137312, a study of Healthy and Solid Tumor, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand how the body's immune cells respond to a new type of vaccine (neoantigen vaccine) designed to help the immune system recognize and fight cancer. To do this, the study team will collect a research specimen from participants to study their immune cells' reactions to the neoantigen vaccine. This research will help researchers learn more about how these vaccines might work to protect or treat against cancer.
Conditions Studied
Interventions
- PROCEDURE Apheresis
- PROCEDURE Blood Draw
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-12-16 |
| Est. Completion | 2028-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07137312
The ClinicalTrials.gov registry entry for NCT07137312 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Apheresis is the first listed.
NCT07137312 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT07137312 about?
NCT07137312 is a clinical study titled "Ex Vivo Expansion (ACT-X)". The purpose of this study is to understand how the body's immune cells respond to a new type of vaccine (neoantigen vaccine) designed to help the immune system recognize and fight cancer. To do this, the study team will collect a research specimen from participants to study their immune cells' react...
What is the current status of trial NCT07137312?
This trial is currently recruiting. The enrollment target is 24 participants. The study started on 2025-12-16. Estimated completion is 2028-10.
What conditions does trial NCT07137312 study?
This clinical trial studies the following conditions: Healthy, Solid Tumor, Malignant Solid Neoplasm.
What interventions are being tested in trial NCT07137312?
The interventions under investigation include: Apheresis (PROCEDURE), Blood Draw (PROCEDURE).
Who is sponsoring clinical trial NCT07137312?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07137312 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.